Related Experiment Videos

SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo

M E Goldman1, L J Ransone, D W Anderson

  • 1Department of Pharmacology, Signal Pharmaceuticals, Inc, San Diego, California 92121, USA. mgoldman@signalpharm.com

Abstract

No abstract available in PubMed .

Related Concept Videos